The current COVID-19 pandemic has shed new light on the challenges around global availability of medicines. Countries worldwide are looking into measures to increase supply and secure access, including strengthening local production of essential medicines. During this webinar, Dr. Gabriela Chaves will present different approaches to stimulate local production of medicines adopted in Brazil over three decades, highlighting the connections between health and industrial policies and drawing lessons learned. Pauline Londeix will present research findings from a recent report on the potential re-location of pharmaceutical production at the European Union level and its member States, including examples of alternative models of production.

Speakers

• Gabriela Costa Chaves, Independent Researcher
• Pauline Londeix, Co-founder, Observatoire de la Transparence dans les Politiques du Médicament (OTMeds)
• Moderator: Suerie Moon, Co-Director, Global Health Centre; Professor of Practice, The Graduate Institute, Geneva
   

Event Materials

• Biographies of Speakers
• Chaves GC (2016) Interfaces entre produção local e acesso a medicamentos no contexto do Acordo TRIPS da Organização Mundial do Comércio (PhD thesis), Escola Nacional de Saúde Pública Sergio Arouca, Rio de Janeiro.
• Chaves GC, Oliveira MA, Bermudez JAZ (2021) Brazil: Patent Barriers and Access to Medicines
 Through the Public Health System, in Intellectual Property Law and Access to Medicines - TRIPS Agreement, Health, and Pharmaceuticals (ed. Ragavan S and Vanni A).
• OTMeds (2021) Relocalisation de l’industrie pharmaceutique en Europe et dans les états membres.
• Presentation by Gabriela Costa Chaves
• Presentation by Pauline Londeix
• Q&A Session with the Audience